Release Date: 21/06/18 09:46 Summary: TMT DELIVERS ROBUST GABANINTHA PRE FEASIBILITY STUDY Price Sensitive: Yes Download Document 2.89MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%